Abstract
This report describes unrelated umbilical cord blood transplantation for a 10-month-old infant boy with mucopolysaccharidosis IIB (Hunter syndrome), an X-linked metabolic storage disorder due to deficiency of iduronate sulfatase. Two years after transplant ∼55% normal plasma enzyme activity has been restored and abnormal urinary excretion of glycosaminoglycans has nearly completely resolved. The boy has exhibited normal growth and development after transplant. Nine months after transplant he developed severe autoimmune hemolytic anemia and required 14 months of corticosteroid treatment to prevent clinically significant anemia. Bone marrow transplantation for Hunter syndrome and post-transplant hemolytic anemia are reviewed. Bone Marrow Transplantation (2000) 25, 1093–1097.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Neufeld EF, Muenzer J . The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The Metabolic Basis of Inherited Disease 6th edn. McGraw-Hill: New York 1995 pp2465–2494
Young ID, Harper PS, Newcombe RG, Archer IM . A clinical and genetic study of Hunter's syndrome. 2. Differences between the mild and severe forms J Med Genet 1982 19: 408–411
Young ID, Harper PS . Incidence of Hunter's syndrome Hum Genet 1982 60: 391–392
Young ID, Harper PS, Archer IM, Newcombe RG . A clinical and genetic study of Hunter's syndrome. 1. Heterogeneity J Med Genet 1982 19: 401–407
Li P, Bellows AB, Thompson JN . Molecular basis of iduronate-2-sulphatase gene mutations in patients with mucopolysaccharidosis type II (Hunter syndrome) J Med Genet 1999 36: 21–27
Gort L, Chabas A, Coll MJ . Hunter disease in the Spanish population: molecular analysis in 31 families J Inher Metabol Dis 1998 21: 655–661
Young ID, Harper PS . The natural history of the severe form of Hunter's syndrome: a study based on 52 cases Dev Med Child Neurol 1983 25: 481–489
Young ID, Harper PS . Mild form of Hunter's syndrome: clinical delineation based on 31 cases Arch Dis Child 1982 57: 828–836
McKinnis EJ, Sulzbacher S, Rutledge JC et al. Bone marrow transplantation in Hunter syndrome J Pediatr 1996 129: 145–148
Li P, Thompson JN, Hug G et al. Biochemical and molecular analysis in a patient with the severe form of Hunter syndrome after bone marrow transplantation Am J Med Genet 1996 64: 531–535
Vellodi A, Young E, Cooper A et al. Long-term follow-up following bone marrow transplantation for Hunter disease J Inher Metabol Dis 1999 22: 638–648
Whitley CB, Belani KG, Chang PN et al. Long-term outcome of Hurler syndrome following bone marrow transplantation Am J Med Genet 1993 46: 209–218
Bergstrom SK, Quinn JJ, Greenstein R, Ascensao J . Long-term follow-up of a patient transplanted for Hunter's disease type IIB: a case report and literature review Bone Marrow Transplant 1994 14: 653–658
Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors New Engl J Med 1998 339: 1565–1577
Chen FE, Owen I, Savage D et al. Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplant Bone Marrow Transplant 1997 19: 491–495
Sherer Y, Shoenfeld Y . Autoimmune diseases and autoimmunity post-bone marrow transplantation Bone Marrow Transplant 1998 22: 873–881
Sullivan KM, Witherspoon RP, Storb R et al. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation Blood 1988 72: 546–554
Hart DNJ, Fearnley DB . The effect of GvHD on the hematopoietic system. In: Ferrara JLM, Deeg HJ, Burakoff SJ (eds) Graft-vs.-Host Disease 2nd edn. Marcel Dekker: New York 1997 pp447–477
Drobyski WR, Potluri J, Sauer D, Gottschall JL . Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation Bone Marrow Transplant 1996 17: 1093–1099
De Lord C, Marsh JC, Smith JG et al. Fatal autoimmune pancytopenia following bone marrow transplantation for aplastic anaemia Bone Marrow Transplant 1996 18: 237–239
Wang WC . Evans syndrome in childhood: pathophysiology, clinical course, and treatment Am J Pediatr Hematol Oncol 1988 10: 330–338
Kottaridis PD, Rees H, Smith G et al. A fatal case of autoimmune thrombocytopenia with an IgM anti-GPIb/IX following one antigen mismatched unrelated donor bone marrow transplantation Bone Marrow Transplant 1999 23: 739–741
Gilliland BC . Autoimmune hemolytic anemia. In: Rossi EC, Simon TL, Moss GS, Gould SA (eds) Principles of Transfusion Medicine 2nd edn: Williams & Wilkins: Baltimore 1996 pp101–120
Braun SE, Aronovich EL, Anderson RA et al. Metabolic correction and cross-correction of mucopolysaccharidosis type II (Hunter syndrome) by retroviral-mediated gene transfer and expression of human iduronate-2-sulfatase Proc Natl Acad Sci USA 1993 90: 11830–11834
Stroncek DF, Hubel A, Shankar RA et al. Retroviral transduction and expansion of peripheral blood lymphocytes for the treatment of mucopolysaccharidosis type II, Hunter's syndrome Transfusion 1999 39: 343–350
Thompson JN, Nowakowski RW . Enzymatic diagnosis of selected mucopolysaccharisoses: Hunter, Morquio, Type A, and Sanfilippo types A, B, C, and D and procedures for measurement of 35SO4-glycosaminoglycans. In: Hommes F (ed) Techniques in Diagnostic Human Biochemical Genetics: A Laboratory Manual John Wiley & Sons: New York 1991 567–586
Acknowledgements
This work was supported in part by Clinical Oncology Career Development Award CDA-96-61 from the American Cancer Society (CAM).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mullen, C., Thompson, J., Richard, L. et al. Unrelated umbilical cord blood transplantation in infancy for mucopolysaccharidosis type IIB (Hunter syndrome) complicated by autoimmune hemolytic anemia. Bone Marrow Transplant 25, 1093–1097 (2000). https://doi.org/10.1038/sj.bmt.1702397
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702397
Keywords
This article is cited by
-
Effect of donor chimerism to reduce the level of glycosaminoglycans following bone marrow transplantation in a murine model of mucopolysaccharidosis type II
Journal of Inherited Metabolic Disease (2015)
-
Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease
Orphanet Journal of Rare Diseases (2011)
-
Cord blood in regenerative medicine: do we need immune suppression?
Journal of Translational Medicine (2007)
-
Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients
Bone Marrow Transplantation (2007)
-
Acute autoimmune hemolytic anemia following unrelated cord blood transplantation as an early manifestation of chronic graft-versus-host disease
Bone Marrow Transplantation (2001)